
VETLUX Veterinary Canine DEA 1.1 Blood Typing Test
Formula: Engineered for rapid detection of DEA 1.1 status (positive/negative) in dogs, crucial for transfusion and breeding management.
Primary Use: For pre-transfusion screening, breeding risk assessment, and preventing neonatal hemolysis in dogs.
Key Benefit: Enables rapid DEA 1.1 phenotype determination to avoid severe transfusion reactions and breeding-related hemolytic complications.
Specifications & Features:
Detects: DEA 1.1 status (positive/negative).
Importance: DEA 1.1 is highly immunogenic; mismatched transfusion can cause acute hemolytic reaction (RBC destruction within 12 hours), hemoglobinuria, hyperbilirubinemia, delayed hemolytic reactions, and neonatal hemolysis (triggered in ~25% of pregnancies when mating with DEA 1.1+ males).
Advantages: Simple (no special equipment/environmental needs), high accuracy (easy visual reading), less blood required (1–2 drops), high efficiency (blood type known in 5–10 minutes).
Test Procedure:
Prepare Materials: Let all materials (specimen, test device) reach 15–25°C. Remove the test card from the foil pouch and place it horizontally.
Sample Preparation: Use a pipette to collect whole blood (EDTA or heparin, fresh or stored at 2–8°C for ≤3 days), add 1–2 drops (approx. 40μL) to assay buffer and mix well.
Apply Sample: Drop 2 drops (approx. 40μL) of the diluted sample into the test card’s sample hole.
Interpret Result: Read the result within 5–10 minutes; results after 10 minutes are invalid.
Applications: Essential for veterinary clinics to ensure safe blood transfusions in dogs and manage breeding programs, preventing life-threatening reactions and neonatal complications through accurate blood type identification.
